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PepExplorer aids in the biological interpretation of de novo sequencing re-
sults; this is accomplished by assembling a list of homolog proteins obtained
by aligning results from widely adopted de novo sequencing tools against a
target-decoy sequence database. Our tool relies on pattern recognition to en-
sure that the results satisfy a user-given false-discovery rate (FDR). For this,
it employs a radial basis function neural network that considers the precursor
charge states, de novo sequencing scores, the peptide lengths, and alignment
scores. PepExplorer is recommended for studies addressing organisms with
no genomic sequence available. PepExplorer is integrated into the PatternLab
for proteomics environment, which makes available various tools for down-
stream data analysis, including the resources for quantitative and differential
proteomics. C© 2015 by John Wiley & Sons, Inc.
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INTRODUCTION
Shotgun proteomics data analysis relies on several distinct techniques for interpreting
data generated by mass spectrometers to ultimately provide a better understanding of
biological systems. The gold-standard strategy, called peptide spectrum matching (PSM),
relies on comparing experimental spectra against those theoretically generated from a
sequence database (Eng et al., 1994). Yet, the absence of curated databases limits the
application of PSM to unsequenced organisms. De novo is a technique for interpreting
mass spectra that has roots in a different paradigm; it aims at predicting peptides by
interpreting mass spectra without requiring a database. Therefore, de novo sequencing is
commonly applied when there is a lack of genomic or proteomic databases and thus is
complementary to PSM; it can also be used, say, for the discovery of new proteoforms.
The output of de novo tools is limited to a list of peptides with confidence scores (Seidler
et al., 2010) and therefore does not provide a direct interpretation at the protein level.
To overcome the aforementioned limitation, a class of software that performs BLAST-
like analyses using sequences from closely related organisms and substitution matrices
tailored to the task at hand emerged (Shevchenko et al., 2001; Junqueira et al., 2008).
PepExplorer refines the latter by introducing a target-decoy similarity search followed by
filtering results with a radial basis function neural network (RBF-NN) to satisfy a given
false-discovery rate (FDR). The results are presented as a user-friendly and dynamic
report that includes commonly used features found in proteomic studies such as protein
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coverage and number of matching peptides. This qualifies PepExplorer as a software
for statistically dealing with protein inference from peptide de novo sequence data and
aiding in de novo interpretation at the protein level (Leprevost et al., 2014).
The following protocols describe the process of analyzing de novo sequencing results
(post de novo analysis) with PepExplorer. We provide protocols for creating a database
tailored to the study at hand, as well as to set the appropriate parameters and to perform
data analysis and interpretation using the dynamic report.
PepExplorer is part of the software PatternLab for proteomics (Carvalho et al., 2012,
UNIT 3.19), which is freely available at http://patternlabforproteomics.org.
BASIC
PROTOCOL 1
CREATING AND FORMATTING A DATABASE FOR PepExplorer ANALYSIS
Creating a database for PepExplorer is the most critical step when doing post de novo
analysis. Attention is important at this step regardless of whether the aim is to obtain
identifications complementary to those reported by PSM or to unravel the proteome of
a recently discovered organism. The key aspect is to select sequences from organisms
phylogenetically related to the organism at hand. If the study addresses a specific class
of proteins, such as, say, kinases, the database should contain different members of that
family, from different organisms.
Protein sequences can be obtained from curated or non-curated databases. Curated
databases are smaller and populated only with curated or reference sequences that usually
have some functional information associated with them, which aids in determining the
localization and function of proteins; NCBI RefSeq and SwissProt are examples of cu-
rated databases. Curated databases are the product of intensive labor, every registry being
reviewed individually. Non-curated databases, on the other hand, are larger because not
all registries go through a review process; this causes redundancy, as well as sequences
originating from experimental errors (e.g., being sequenced together with the vector),
and even sequences having a low sequence quality, which means they can be wrong.
The positive aspect of using a non-curated database lies in the possibility of validating
new variants and uncharacterized sequences. However, one should also bear in mind that
searching against larger databases requires more computational resources and may result
in sensitivity loss (Borges et al., 2013).




A PC running an English version of Windows 7 or higher, with at least 4 GB of
RAM and at least 100 GB of storage space
Software
Microsoft .NET framework 4.5 or later
PatternLab for proteomics, which can be freely downloaded from the project’s Web
site (http://patternlabforproteomics.org)
1. The instructions to prepare a database for analysis are available in UNIT 3.19 (Carvalho
et al., 2012; “PatternLab: From Mass Spectra to Label-Free Differential Shotgun
Proteomics”), Basic Protocol 1, “Preparing a Sequence Database to be Searched by
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The aforementioned protocol details how to generate a target-decoy database containing




PepExplorer provides the user with a set of parameters that can be adjusted to optimize
the analysis process (Fig. 13.27.1). These parameters are reviewed here.
Necessary Resources
Hardware
A PC running an English version of Windows 7 or higher, with at least 4 GB of
RAM and at least 100 GB of storage space
Software
PatternLab for proteomics, which can be freely downloaded from the project’s Web
site (http://patternlabforproteomics.org)
Files
A results file from one of the compatible de novo sequencing tools available:
PepNovo (Frank and Pevzner, 2005), PNovo+ (Chi et al., 2010), or PEAKS (Ma
et al., 2003).
A database generated as specified in Basic Protocol 1
1. To access PepExplorer, execute PatternLab, then click on the Filter drop-down menu
and then on PepExplorer.
2. Click the Browse button on the Database field and then select the sequence database.
Figure 13.27.1 PepExplorer user interface. This is the main window where all analysis parameters are set.
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3. Write the label used for tagging decoy sequences as in the database. If Basic Protocol
1 was followed, all reverse sequences will have a Reverse tag in their headers.
4. The Alignment section allows the setting of parameters related to sequence align-
ment. Their values determine how the alignment algorithm will penalize gaps, gap
extensions, and non-matching amino acids. The default values (shown in Fig. 13.27.1)
were obtained by extensively testing all combinations on a P. furiosus dataset and
verifying the combination that yielded the optimal result. Nevertheless, the default
combination is not necessarily optimal for the experiment at hand. We suggest also
experimenting with more stringent values.
5. Parameters:
a. Open Gap: The penalization for opening a gap in the alignment.
b. Extend Gap: The penalization for extending a gap that was already open during
sequence alignment.
c. TopHits/Peptide size: How many predicted peptides from each spectrum are con-
sidered to be aligned and the peptide size itself, respectively.
d. De novo score cutoff: Every de novo tool that is compatible with PepExplorer
generates a list of peptide predictions, each having a de novo score reflecting a
confidence. This parameter restricts the analysis only to de novo results with a
score higher than the value set here.
e. Matrix: The sequence alignment is scored according to the substitution matrix
specified in this field. PepExplorer makes available the PAM30MS matrix, tailored
to mass spectrometry data analysis (Shevchenko et al., 2001).
6. Database format: Select from which online sequence database the sequences were
obtained: Generic FASTA, NCBI, UniProt, NextProt. The Generic FASTA format
accepts headers that are composed by the Protein ID, followed by a blank space, and
then by a description.
7. Click the Browse button in the de novo output section and specify the directory
containing the de novo results files. Alternatively, paste the directory path in the text
box.
If the user only has a list of peptides not scored by any of the aforementioned de novo
tools, this list can be pasted into the lower text box contained in this section.
8. Lastly, select the de novo sequencing software employed by using the corresponding
pull-down menu.
9. Press Start.
The time necessary to conclude the analysis depends on database size and on the number of
de novo results to be analyzed. Once PepExplorer has finished, the Data Analysis window
will pop open and the results should be saved.
GUIDELINES FOR UNDERSTANDING RESULTS
After the software completes analyzing the data, it will open a results window showing
the analysis report (Fig. 13.27.2). That figure shows the dynamic report generated after
the analysis is finished. The first tab, called Report, lists the identified proteins and
their respective matching peptides. There are two groups of elements on this window,
Filter and FDR. The former makes available parameters that affect the protein selection
stringency and how the protein list will be organized. For example, if the alnCount
counter is set to 2, only the proteins with more than 2 alignments will be shown. The
MinFullIdent parameter specifies the minimum similarity that a de novo result must have
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Figure 13.27.2 The dynamic report shows inferred proteins based on the sequence alignment and the RBF-NN classifi-
cation. By adjusting the parameters at the top of the window, it is possible to rearrange results to better fit the research.
Figure 13.27.3 Dynamic Report Window. The report shows the list of identified proteins and the matching peptides.
When the inferred proteins are selected from the upper panel, the bottom list shows all the peptides that aligned against
the protein. It also shows further information on the analysis, like the alignment size, the number of peptides, how many
gaps it has, and so on.
The actual FDR value is shown in the second element. The values change every time the
list is filtered with one of the controls on the left. It informs both the FDR for peptide
analysis and that for protein analysis.
The results are presented in both the upper and the lower panel. The upper list provides
information on the identifications: database protein length, the peptide coverage, the
number of matched sequences, the number of spectra, and description. Clicking on any
row will update the content of the bottom panel to reflect the peptide information of
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Figure 13.27.4 Protein Coverage and Group Analysis window. Text-based representation of the protein coverage accord-
ing to the identified peptides.
open the Protein Coverage and Group Analysis window (Fig. 13.27.4), which shows a
graphical representation of the coverage and depicts, using text, which amino acids could
be explained through de novo sequencing.
The coverage window (Fig. 13.27.5) also provides access to a cloud service that enables
the dynamic prediction of the domains of the identified protein (Leprevost et al., 2013).
This is accomplished by sending the sequence to our servers; on our end, the HMMR
algorithm is executed (Punta et al., 2012). After completing the analysis, the window
will reflect the domains pertaining to that protein.
The second tab, called Plotting (Fig. 13.27.6), was conceived as a visual way to view
the topography and decision surface of the RBF-NN over the results. As the RBF-NN
considers the de novo peptide sequence length, de novo score, and alignment scores,
not all features are represented in the two-dimensional plot. The upper controls allow
selecting which features should be considered as x axis and y axis in the plot.
The plotting area located in the upper part of the window represents the distribution of
the alignments based on two features chosen out of three. We note that the analysis itself
and the classification process take into account, simultaneously, all the features (i.e., de
novo score, alignment score, and peptide length) of the alignments between the proteins
and the peptide.
The plotting area and the points are composed of different tones of red or blue. A point
is red if its corresponding de novo result aligned against a decoy sequence; it is blue
otherwise. The background color tone is correlated to the RBF-NN output; regions of
higher confidence are dark blue; they become red otherwise. The area where both colored
points are found in approximately the same proportions generally becomes a “gray zone,”
as it becomes less probable that the points will be correctly classified.
A histogram is displayed right below the plotting area; it is a complementary way of
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Figure 13.27.5 Domain Inference Window. This window allows the user to use an on-line service to predict functional
domains in proteins. Also, allows to visualize the protein coverage regarding the matching peptides. The blue bar represents
the identified protein. The orange bars represent regions of the protein that can be confirmed with identified peptides.
Figure 13.27.6 RBF-NN classification viewer. This window provides the user with a visual form of representing the
classification process executed by the neural network. The plotting area shows a two-dimensional representation of the
RBF-NN decision surface. Blue dots represent de novo results that aligned against target proteins; likewise, red represent
those that aligned against decoys. The background color intensity is correlated with the RBF-NN confidence; the stronger
the blue, the higher the confidence. The lower panel displays a histogram of the distribution of scores for the “red” and
“blue” classifications.
13.27.7
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brief, the x axis represents the RBF-NN output value and the y axis the number of de
novo results satisfying that score. Likewise, blue bars represent results that aligned with
forward sequences, and red bars represent decoy alignments. If an FDR of, say, 1% is
specified by the user, the algorithm will establish an RBF-NN cutoff score in such a way
that the summed area of the red bars represent 1% of the total area.
COMMENTARY
Background Information
Most of what we know of biology has been
derived from the study of cell lines and model
organisms. Even so, there are many examples
of groundbreaking discoveries resulting from
the study of species that, until then, were given
little scientific importance. For example, who
would have imagined that a study of organ-
isms living in thermal waters could become
a precursor to a revolution in molecular biol-
ogy? Indeed, the Taq polymerase was discov-
ered while studying Thermus aquaticus (Saiki
et al., 1985). This thermostable DNA poly-
merase enzyme paved the way for Kary Mullis
to later introduce the Polymerase Chain Re-
action (PCR) method, capable of amplifying
short segments of DNA (Bartlett and Stirling,
2003), a discovery that would lead to his being
awarded the 1993 Nobel Prize in Chemistry.
The mainstream in proteomics has been
to compare experimental spectra against the-
oretical spectra generated from a sequence
database (Eng et al., 1994). Nevertheless, only
a small fraction of the species have Reference
Sequences deposited in the NCBI database
(http://www.ncbi.nlm.nih.gov/refseq/). There
is a consensus that natural biological resources
must be better assessed: the exploratory space
for groundbreaking discoveries beyond exist-
ing model organisms and cell lines is virtually
unlimited, but the proper tools to mine this pro-
teomosphere are in their infancy (Junqueira
and Carvalho, 2012). Continual advances in
mass spectrometry, with yearly releases of
more sensitive, faster, and higher-resolution
equipment, make de novo sequencing more
and more of a mainstream approach. PepEx-
plorer aims to shorten the gap in efficiency
between the proteomic interpretation of un-
sequenced organisms and the widely adopted
PSM approach, notwithstanding the many lim-
itations that still exist. For example, in our
view, there is still much room for improvement
on how sequence alignment is done; while
current methods excel for genomic data, they
do not take into account the shortcomings of
mass-spectrometry data, such as the possibil-
ity of de novo sequencing swapping neigh-
boring amino acids when spectral peaks are
missing.
Other applications in which PepExplorer
can be particularly useful are those address-
ing samples with many mutations or poly-
morphisms (e.g., venoms), as well as those
in metaproteomics (Muth et al., 2015). Cur-
rently, there is no one-fits-all approach for han-
dling such problems, and there are approaches
that are complementary to PepExplorer. For
example, blind modification searches, in our
hands, have provided complementary results
to PepExplorer (Na et al., 2012); this type
of approach stems from a different paradigm
where a sequence database is used for match-
ing mass spectra, but in a much “looser” way.
Spectral networking is also a powerful ap-
proach for treating unsequenced organisms;
this strategy capitalizes on overlapping spec-
tra to improve on de novo sequencing and
then perform alignment against a sequence
database. Blind-PTM approaches and spectral
networks allow the discovery of unanticipated
PTMs (a limitation of PepExplorer) and muta-
tions/polymorphisms (Bandeira, 2007). How-
ever, in our hands, PepExplorer has proven to
be more sensitive, but still complementary, to
blind-PTM approaches when not considering
PTMs. The proper, combined use of this ar-
senal of tools, applied to the vast biological
diversity, holds the keys to unlocking a vast
treasure trove of knowledge in biology.
Troubleshooting
My analysis is taking too long
The current version of PepExplorer places
a high burden on the computer. Smaller
databases significantly speed up the search.
PepExplorer can use multiple computing
cores, so we strongly recommend using com-
puters with as many cores as possible. De-
pending on the available hardware, the process
could take hours or even days. We are currently
improving on the code to soon disclose a faster
PepExplorer.
I’m getting very few proteins in my results
Peptide de novo sequencing is a technique
that strongly depends on high data quality. For
example, high-resolution tandem mass spec-
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double check if the organism selected for gen-
erating the sequence database is “close” to the
one being analyzed.
The domain prediction service (Fi°Cloud) is
not working or it is taking too long
The domain prediction service relies on a
Web server that must be contacted via the
Internet. It is possible for the communica-
tion with that server to be compromised by
different factors, like no connection to the
Internet or some firewall blockade. If there
are problems using this feature, we recom-
mend trying it later or from another Internet
connection.
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